Femtech.Design
The Product Design Playbook for Women’s Health Innovation
Learn the frameworks, strategies, and patterns I’ve developed by working directly with 65 femtech startups and the world's largest medtech, life science, insurance and digital health companies.
Expected release Q4, 2025

You're building something that matters.
Let's make sure it succeeds.
The founders reshaping women's health aren't just passionate. They're strategic. They know that breakthrough products require deep empathy and smart design, clinical rigor and user trust, mission-driven purpose and market-ready execution.I've spent my career designing products used by hundreds of millions of people. Since 2022, I’ve focused that experience on women’s health. Through Femovate, I’ve worked hands-on with 65 femtech startups and invested $2 million in design capital to help founders build solutions that women will use and healthcare systems are ready to adopt.
This playbook brings together what I’ve learned. Frameworks, strategies, and shortcuts that help mission-driven teams move faster and build smarter. From fertility to menopause, diagnostics to mental health — these are the design principles that turn good ideas into products that last.
The market is waiting, let's get women the products they deserve.
About Me
My obsession with healthcare began at WellDoc, where I had the opportunity to work with the pioneers of digital therapeutics. Inspired by the possibilities of combining behavioral science, wearable technologies and clinical rigor to deliver measurable health improvements, I shift the focus of my design consultancy to health.
To-date I've led design and validation for dozens of healthcare products touching 600M lives for companies including Johnson & Johnson, Cigna, Novo Nordisk, and award winning AI startups AmalgamRx and ClosedLoop.ai.







About Femovate
My design studio created Femovate in 2022 to accelerate the investment in, and launch of, women's health innovation. Since then we've invested $2M in design capital in 60 early-stage femtech startups. The startups, in turn, have launched 30 products, raised over $130 million from investment and grants, four have raised a Series A, and 7 have received FDA clearances.
Unicorn
"The Femovate team has deep experience in women's health so rather than starting from zero, we were starting from shared understanding. (The) user interviews were powerful to deepen our understanding of a new customer segment . We believe that their help has been instrumental in the success of our newly launched product -- built by women, for women."

Unicorn
Theresa Neil and her team are outstanding partners. They brought their considerable experience in femtech and medtech to help us design our patient monitor UI. Their approach to design is creative, strategic, and centered around our users. They also went out of their way to point us to additional opportunities in their network to help us grow our brand and business. I highly recommend partnering with (Femovate) for their exceptional service and UX design!

Unicorn
"Eli has worked with (Femovate) now for several months on the user experience of our mobile app, which is one component of our hormone monitoring system. Beyond providing extensive knowledge on best practices for designing the UX medical devices with a paired mobile app, they investigated what objectives we wanted our users to achieve and created lo-fi and hi-fi wireframes to test with users and guide the requirements for our software developers."

Unicorn
"Working with (Femovate) was a fantastic experience. They not only exceeded our expectations by delivering a modern and user-friendly app frame, but they also provided invaluable insights and guidance. Their attention to detail and collaborative approach made the entire process seamless and truly enjoyable."

Unicorn
"The Femovate program truly prepared our team for a better user experience during our first pilot study. The team has the subject matter expertise that we needed for our digital health technology."

Unicorn
"Great! A super organized team and we were able to get all of the details that we wanted included on our provider/researcher dashboard."

Unicorn
"Theresa and Karin aren't just design professionals—they're true partners who have gone above and beyond at every turn. Their deep understanding of the healthcare landscape has been incredibly impressive, allowing them to provide insights that go far beyond typical design work. I can confidently say that Femovate has been more than a design agency—they've been true collaborators who have significantly elevated our project. Theresa and Karin's expertise, passion, and partnership have been instrumental in bringing our vision to life. If you're looking for a design team that will truly understand your mission and help you exceed your goals, this is the team to call."

Unicorn
"Working with (Femovate) has been eye opening, they are a wealth of technical expertise. Beyond providing deliverables necessary for our solution, they have provided a wealth of coaching, guidance and knowledge specific to the ever evolving industry - health tech innovation."

Unicorn
"Working with Theresa and the rest of the team has been a game-changer! They supported us flashing out our product and have made our UX/UI journey so compelling. Theresa is an experienced, hard working professional, and on a personal level, someone who is great to work with. Their team has had a profound impact on our work and we are so grateful to have worked with them."

Unicorn
"We had the absolute pleasure of working with (Femovate) on UX designs for our healthtech solution, as part of the Femovate programme. From the beginning, the process has been easy, straightforward and enjoyable. Theresa and Karin were incredibly supportive and highly professional at every stage of the partnership. We had a number of pivots in what we needed and they patiently guided us through this, helping us pin down our product strategy, UX design for key workflows, and design kits. They are deeply dedicated and experienced in this sector, and I am very much looking forward to working with them further in future."
